Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

HENRY SCHEIN, INC.

(HSIC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Henry Schein : Announces Virtual Presence at Greater New York Dental Meeting Focused on 3D Imaging, 3D Printing, and CAD/CAM Solutions

11/25/2020 | 08:05am EST

Company Committed to Delivering ‘Live’ Experience with Seven Booths, Daily Live Chats, Online Education, and Discussions with Industry Leaders via Facebook

Henry Schein, Inc. (Nasdaq: HSIC) today announced its virtual presence at the Greater New York Dental Meeting (GNYDM), featuring dedicated booths for 3D imaging, 3D printing, and CAD/CAM solutions.

In lieu of a physical event as a result of COVID-19, visitors to Henry Schein’s seven virtual booths can explore product information, educational offerings, and industry thought-leadership events. The Henry Schein virtual experience will include an expanded portfolio of solutions including teledentistry solutions, modified practice design, and dedicated booths.

From November 27 through December 2, attendees can explore the Company’s offerings by visiting a dedicated Greater New York Dental Meeting page on Henry Schein’s website, and interact with representatives at the following virtual booths:

  • Henry Schein Dental (Booth #1565)
  • 3D (CBCT) Imaging Center of Excellence (Booth #1657)
  • CAD/CAM & 3D Printing Center of Excellence (Booth #1557)
  • Practice Design (Booth #1656)
  • Henry Schein One (Booth #1665)
  • Henry Schein ProRepair (Booth #1857)
  • Henry Schein Professional Practice Transitions (Booth #1757)

“Every year, the Greater New York Dental Meeting gathers thousands of attendees to experience the latest innovations in dentistry, learn new techniques, and explore opportunities with education courses,” said AJ Caffentzis, President, U.S. Dental Distribution, Henry Schein. “While this year’s meeting is virtual, attendees can continue to rely on Henry Schein to deliver the best possible trade show experience, providing a comprehensive look at our innovative portfolio of solutions, a rich lineup of education courses, and engaging conversations with key industry leaders.”

Key Highlights

Henry Schein is committed to providing education, integration, and support that customers can rely on to run an efficient, successful practice. Henry Schein and its supplier partners will host a series of virtual presentations and webinars showcasing the choice of innovative, scalable digital technologies as well as business solutions that can be effectively integrated with the clinical workflow. Featured presentations include:

  • Technologies that can Mitigate Risk in Dentistry, Presented by Dr. Gary Severance, Executive Leader of Professional Services, Henry Schein;
  • From Vision to Completion: What Do You Need to Know When Building a Dental Office?, Presented by Jennifer Rhode, Manager, Dental Office Design, Henry Schein;
  • 2020 Conebeam Review, Presented by Matt Kunzler, Digital Restoration Specialist, Henry Schein;
  • The Power and Potential of Digital Dentistry, Presented by Dr. Wally Renne, DMD; and
  • Point of Care Diagnostic Tests for the Dental Setting, Presented by Dana Becker, Strategic Business Consultant, Henry Schein; David Kochman, Vice President, Corporate Affairs and Deputy Chief of Staff, Henry Schein; and Dr. Ari Levy, MD.

“Diagnostic testing is a value-added service that dentists can provide to their patients as well as implement to help maintain a safer workplace for themselves and their staff,” said Dominick Gallo, Vice President of Process Excellence for Henry Schein Dental. “Henry Schein is making available both rapid point of care and lab-based molecular and antigen testing solutions to dental professionals. We are actively working to support dental practices in becoming licensed diagnostic labs, which will enable dentists to perform tests to address the immediate pandemic as well as the long-term need for the integration of oral health and total health.”

In addition, Henry Schein will broadcast #scheinchats, the Company’s signature social media series available on Facebook that will offer engaging conversations with perspectives from oral health professionals and industry-leading supplier partners. The GNYDM #scheinchat lineup will include:

  • Stanley Bergman, Chairman and CEO of Henry Schein, and Sydney Shapiro, President of the American Student Dental Association (ASDA), discussing How Dental Students are Navigating the COVID-19 Pandemic;
  • Dr. Bruce Lieberthal, Chief Innovation Officer of Henry Schein, and Dr. Wen Shi, Chief Executive Officer of The Forsyth Institute, discussing The Evolution of COVID-19 Diagnostic Testing;
  • David Kochman, Vice President, Corporate Affairs and Deputy Chief of Staff of Henry Schein, and Dr. Jessica Lee, President of the American Association of Pediatric Dentists, discussing Integrating Diagnostic Testing into the Dental Practice;
  • Jack Abrams, Director, Corporate Business Development, Henry Schein, and Brant Herman, Chief Executive Officer of MouthWatch, discussing The Role of Teledentistry in the Dental Practice.

Visit www.henryscheindental.com/gnydm for details on the business solutions and integrated technologies available to help dental practitioners operate a productive practice, attain business goals, and assist in the delivery of quality patient care.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.


© Business Wire 2020
All news about HENRY SCHEIN, INC.
01/05HENRY SCHEIN : Acquires Majority Stake in Prism Medical Products, Marking Entran..
MT
01/05HENRY SCHEIN : Acquires Majority Interest in Prism Medical Products, Enters Home..
BU
01/04HENRY SCHEIN : Baird Upgrades Henry Schein to Outperform From Neutral, Adjusts P..
MT
01/04HENRY SCHEIN : Completes Joint Venture with Casa Schmidt
BU
2020HENRY SCHEIN, INC., II : Post-Argument Analysis
AQ
2020HENRY SCHEIN : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020HENRY SCHEIN : Medical Enhances Access to Ansell Isolation Gowns Amid COVID-19, ..
BU
2020HENRY SCHEIN : Medical Helps Automate and Streamline Patient Waiting Room Proces..
BU
2020HENRY SCHEIN : to Ring the Nasdaq Stock Market Opening Bell
BU
2020HENRY SCHEIN : Arbitrability Returns To The Supreme Court In Henry Schein, Inc. ..
AQ
More news
Financials (USD)
Sales 2020 9 832 M - -
Net income 2020 400 M - -
Net Debt 2020 410 M - -
P/E ratio 2020 24,3x
Yield 2020 -
Capitalization 9 870 M 9 870 M -
EV / Sales 2020 1,05x
EV / Sales 2021 0,91x
Nbr of Employees 19 000
Free-Float 98,6%
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 71,00 $
Last Close Price 69,13 $
Spread / Highest target 30,2%
Spread / Average Target 2,71%
Spread / Lowest Target -14,7%
EPS Revisions
Managers and Directors
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Philip A. Laskaway Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.3.40%9 870
CANTEL MEDICAL CORP.1.09%3 309
AS ONE CORPORATION-7.93%2 926
SHIP HEALTHCARE HOLDINGS, INC.4.88%2 736
OWENS & MINOR, INC.1.92%2 027
JAPAN MEDICAL DYNAMIC MARKETING, INC.-4.06%576